Modelled DT Structure
Method: homology modeling
Template PDB: 5XJY_A
Identity: 52.669%
Minimized Score: -1629.22 kcal/mol
Detail: Structure Info
| General Information of DT | |||||
|---|---|---|---|---|---|
| DT ID | DTD0045 | ||||
| Gene Name | ABCA7 | ||||
| Protein Name | ATP-binding cassette sub-family A member 7 | ||||
| Gene ID | |||||
| UniProt ID | |||||
| TCDB ID | |||||
| 3D Structure |
Modelled DT Structure Method: homology modeling Template PDB: 5XJY_A Identity: 52.669% Minimized Score: -1629.22 kcal/mol Detail: Structure Info |
||||
| Synonyms | ABCA-SSN; ABCA7; ABCX; AD9; Autoantigen SS-N; Macrophage ABC transporter | ||||
| DT Family | ATP-Binding Cassette (ABC) Superfamily ; | ||||
| Tissue Specificity | Expressed in leukocytes (at protein level).Widely expressed. Highly expressed in myelo-lymphatic tissuesincluding peripheral leukocytes, thymus, spleen and bone marrow.Isoform 2 is more abundant in lymph node, spleen, thymus andtrachea than isoform 1 which is more strongly expressed in brainand bone marrow. | ||||
| Function | This transporter is probable ATP-binding cassette (ABC) transporter that plays a role in lipid homeostasis and macrophage-mediated phagocytosis ang binds APOA1 and may function in apolipoprotein-mediated phospholipid efflux from cells and may also mediate cholesterol efflux. | ||||
| Endogenous Substrate(s) | Phospholipids | ||||
| Variability Data of This Drug Transporter (DT) | |||||
|
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
|
(β) Post-translational Modification of This DT |
|||||
|
(γ) Transcriptional Regulation of This DT |
|||||
|
(δ) Epigenetic Regulation of This DT |
|||||
|
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
|
(β) Inter-species Structural Differences |
|||||
|
General Variability Data of This DT (VARIDT 1.0) |
|||||
|
(α) Genetic Polymorphisms of This DT |
|||||
|
(β) Disease-specific Protein Abundances of This DT |
|||||
|
(γ) Species- and Tissue-specific DT Abundances |
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.